Want to see RMTG full AI Analyst Report?
Regenerative Medical Technology Group (RMTG) Income Statement
Regenerative Medical Technology Group Income Statement
Last quarter (Q2 2026), Regenerative Medical Technology Group's total revenue was $4.02M, an increase of 309.02% from the same quarter last year. In Q2, Regenerative Medical Technology Group's net income was $-2.91M. See Regenerative Medical Technology Group’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 5.10M | $ 4.11M | $ 2.41M | $ 1.53M | $ 437.89K | |
| $ 2.81M | $ 2.82M | $ 1.68M | $ 876.97K | $ 150.14K | |
| $ 3.68M | $ 2.38M | $ 2.39M | $ 2.06M | $ 10.08M | |
| Depreciation and Amortization | $ 281.07K | $ 220.56K | $ 310.10K | $ 152.74K | $ 40.86K |
| $ -83.56K | $ 301.74K | $ -3.01M | $ -1.02M | $ -10.11M | |
| $ -867.16K | $ 81.18K | $ -715.23K | $ -1.18M | $ -9.93M | |
| $ -6.95M | $ -5.64M | $ -9.10M | $ -4.39M | $ -2.95M | |
| $ -7.81M | $ -5.56M | $ -9.81M | $ -5.58M | $ -12.88M | |
| $ -7.81M | $ -5.56M | $ -9.81M | $ -5.49M | $ -12.88M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.62 | $ -0.44 | $ -0.79 | $ -0.45 | $ -1.12 |
| Diluted EPS | $ -0.62 | $ -0.44 | $ -0.79 | $ -0.45 | $ -1.12 |
| Weighted Average Shares Outstanding | 12.63M | 12.53M | 12.45M | 12.22M | 11.48M |
| Weighted Average Shares Outstanding (Diluted) | 12.63M | 12.53M | 12.45M | 12.22M | 11.48M |
Currency in USD
